Max India Past Earnings Performance
Past criteria checks 0/6
Max India's earnings have been declining at an average annual rate of -1.3%, while the Healthcare industry saw earnings growing at 28% annually. Revenues have been declining at an average rate of 6.5% per year.
Key information
-1.3%
Earnings growth rate
-10.1%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | -6.5% |
| Return on equity | -20.0% |
| Net Margin | -52.5% |
| Next Earnings Update | 14 Feb 2025 |
Recent past performance updates
Recent updates
Shareholders May Not Be So Generous With Max India Limited's (NSE:MAXIND) CEO Compensation And Here's Why
Sep 17
There's Reason For Concern Over Max India Limited's (NSE:MAXIND) Price
Apr 27Max India Limited's (NSE:MAXINDIA) Business Is Yet to Catch Up With Its Share Price
Dec 27Returns At Max India (NSE:MAXIND) Are On The Way Up
Aug 02Pinning Down Max India Limited's (NSE:MAXIND) P/S Is Difficult Right Now
Jun 01A Look At The Fair Value Of Max India Limited (NSE:MAXIND)
Apr 25Revenue & Expenses Breakdown
How Max India makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,700 | -892 | 1,322 | 0 |
| 30 Jun 24 | 1,814 | -711 | 1,208 | 0 |
| 31 Mar 24 | 1,909 | -564 | 1,146 | 0 |
| 31 Dec 23 | 2,044 | -390 | 782 | 0 |
| 30 Sep 23 | 2,060 | -214 | 739 | 0 |
| 30 Jun 23 | 2,120 | -184 | 694 | 0 |
| 31 Mar 23 | 2,126 | -104 | 772 | 0 |
| 31 Dec 22 | 2,023 | -92 | 661 | 0 |
| 30 Sep 22 | 1,990 | -142 | 630 | 0 |
| 30 Jun 22 | 2,233 | -125 | 610 | 0 |
| 31 Mar 22 | 2,346 | -161 | 652 | 0 |
| 31 Dec 21 | 2,162 | -260 | 695 | 0 |
| 30 Sep 21 | 2,072 | -332 | 797 | 0 |
| 30 Jun 21 | 1,507 | -500 | 844 | 0 |
| 31 Mar 21 | 1,238 | -531 | 973 | 0 |
| 31 Dec 20 | 1,597 | -360 | 907 | 0 |
| 30 Sep 20 | 1,610 | -803 | 907 | 0 |
| 30 Jun 20 | 1,711 | -696 | 920 | 0 |
| 31 Mar 20 | 1,831 | -232 | 951 | 0 |
| 31 Mar 18 | 15,915 | -762 | 5,229 | 0 |
| 31 Mar 17 | 14,410 | -462 | 4,363 | 0 |
| 31 Mar 16 | 9,757 | -646 | 3,112 | 0 |
Quality Earnings: MAXIND is currently unprofitable.
Growing Profit Margin: MAXIND is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MAXIND is unprofitable, and losses have increased over the past 5 years at a rate of 1.3% per year.
Accelerating Growth: Unable to compare MAXIND's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MAXIND is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (33.3%).
Return on Equity
High ROE: MAXIND has a negative Return on Equity (-20.05%), as it is currently unprofitable.